Cargando…
Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials?
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299455/ https://www.ncbi.nlm.nih.gov/pubmed/34837487 http://dx.doi.org/10.1002/cpdd.1044 |
| _version_ | 1784750978365390848 |
|---|---|
| author | Hirano, Masaru Yamada, Masanori Tanaka, Toshiaki Koue, Toshiko Saito, Tomohisa Higashimori, Mitsuo Ochiai, Hisao Yamamoto, Junichi Yaguchi, Saori Mita, Sachiko Hara, Katsutoshi |
| author_facet | Hirano, Masaru Yamada, Masanori Tanaka, Toshiaki Koue, Toshiko Saito, Tomohisa Higashimori, Mitsuo Ochiai, Hisao Yamamoto, Junichi Yaguchi, Saori Mita, Sachiko Hara, Katsutoshi |
| author_sort | Hirano, Masaru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9299455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92994552022-07-21 Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? Hirano, Masaru Yamada, Masanori Tanaka, Toshiaki Koue, Toshiko Saito, Tomohisa Higashimori, Mitsuo Ochiai, Hisao Yamamoto, Junichi Yaguchi, Saori Mita, Sachiko Hara, Katsutoshi Clin Pharmacol Drug Dev Commentary John Wiley and Sons Inc. 2021-11-26 2021-12 /pmc/articles/PMC9299455/ /pubmed/34837487 http://dx.doi.org/10.1002/cpdd.1044 Text en © 2021 The Authors. Clinical Pharmacology in Drug Development published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Hirano, Masaru Yamada, Masanori Tanaka, Toshiaki Koue, Toshiko Saito, Tomohisa Higashimori, Mitsuo Ochiai, Hisao Yamamoto, Junichi Yaguchi, Saori Mita, Sachiko Hara, Katsutoshi Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title | Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title_full | Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title_fullStr | Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title_full_unstemmed | Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title_short | Surveys/Research Exploring Japanese Phase I Studies in Global Drug Development: Are They Necessary Prior to Joining Global Clinical Trials? |
| title_sort | surveys/research exploring japanese phase i studies in global drug development: are they necessary prior to joining global clinical trials? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299455/ https://www.ncbi.nlm.nih.gov/pubmed/34837487 http://dx.doi.org/10.1002/cpdd.1044 |
| work_keys_str_mv | AT hiranomasaru surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT yamadamasanori surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT tanakatoshiaki surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT kouetoshiko surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT saitotomohisa surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT higashimorimitsuo surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT ochiaihisao surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT yamamotojunichi surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT yaguchisaori surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT mitasachiko surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT harakatsutoshi surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials AT surveysresearchexploringjapanesephaseistudiesinglobaldrugdevelopmentaretheynecessarypriortojoiningglobalclinicaltrials |